Capital Market, Entertainment and Initial Public Offering

Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions

Cooley’s 2022 Life Sciences M&A Year in Review

Cooley M&A

JANUARY 25, 2023

Will 2023 see a resurgence of traditional public M&A deals or will macro factors and the looming threat of regulatory review continue to push biotechnology companies down creative paths? It’s a more challenging market environment right now than we’ve seen in many years,” said Charlie Kim , who co-chairs Cooley’s capital markets practice.

M&A

M&A Mergers and Acquisitions Pharmaceutical Collaboration

Investment Banking Today

Cooley’s 2022 Life Sciences M&A Year in Review

Stay Connected